Indus eff of anticoagulants
From Prosit
This page contains development contents which may not yet represent final PROSIT Content.
Effectiveness of Anticoagulants in Secondary Stroke Prevention
I have worked on the medical effectiveness of antigoagulants for secondary stroke prevention. Please find attached results on risk reduction of antigoagulants in major studies i.e. ESPRIT, ESPS2 and CAPRIE.
the problem with these data is that different dosages make interpretations difficult. May be it would be better to focus on the factual event rates rather than per-cent risk reductions...
Comments?